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ABSTRACT
Food allergy, triggered by an aberrant immune response
elicited by orally ingested food allergens, is generated
through a complicated mechanism because the allergen
interacts with the mucosal immune system (the gut-
associated lymphoid tissue, GALT) and the resulting
immune response affects the generation of allergy. This
review will describe the process by which antigens or
allergens are recognized by the GALT and the charac-
teristic immune responses induced thereafter. Orally
administered antigens induce distinct immune responses
in the Peyer’s patches, lamina propria and the intestinal
epithelium. In addition to these local immune responses
in the gut, ingested antigens are known to affect sys-
temic immunity. These may induce a suppressed state of
systemic immune responsiveness, which is called oral
tolerance, or in some cases they may elicit a systemic IgE
antibody response which may lead to allergic reactions.
Information on the regions on food allergens recognized
by T cells and IgE antibodies is important in understand-
ing the fates of food allergens after being recognized by
the GALT. The structure of T and B cell epitopes on food
allergens and the possibility of modulation of allergic
reactions by amino-acid substituted analogs of allergen-
derived peptides will also be discussed.
Key words: altered peptide ligands, epitope, food
allergy, gut-associated lymphoid tissue (GALT), IgE,
oral tolerance. 
INTRODUCTION
Food allergy, triggered by an aberrant immune response
elicited by orally ingested food allergens, is generated
through a complicated mechanism because the allergen
interacts with the mucosal immune system and the resulting
immune response affects the generation of allergy. The
oral administration of antigen or allergen is known to
induce a suppressed state of immune responsiveness,
which is called oral tolerance. Thus, the same allergen can
elicit both the generation and the suppression of allergy. It
is unknown how these interesting immune reactions which
function in opposing directions are controlled by the
mucosal immune system. To understand these complicated
immune responses, the process of recognition of food
allergens and the resulting response by the mucosal
immune system must be elucidated. Initially, this review will
describe the process by which allergens are recognized by
the mucosal immune system and thereafter, characteristic
immune responses and oral tolerance will be described.
The allergic reaction to food, usually a type I reaction,
consists of plural processes such as immunoglobulin (Ig)
E production, IgE binding to mast cells, and inflammation.
However, many problems remain unresolved. For example,
the regions on allergen molecules which are bound by IgE
and T cells should be analyzed. In this review, the structure
of the T and B cell epitopes on food allergens and the
modulation of allergic reactions by amino-acid substituted
analogs of allergen-derived peptides will be described.
FOOD ALLERGENS AND THE GUT-ASSOCIATED
LYMPHOID TISSUE
Many of the food allergens that commonly induce hyper-
sensitivity to food in infants or adults have been identified.
Egg white, milk, and soybean proteins are major food
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allergens in the case of infants. In Japan, cereal proteins
(i.e. proteins in rice, buckwheat and other grains), especi-
ally, are recognized as allergens as infants grow older. The
components of these foods responsible for the disease are
allergenic proteins. After being ingested in the gut, such
allergenic proteins interact with the mucosal immune
system of the gastrointestinal tract, namely the gut-associ-
ated lymphoid tissue (GALT). The GALT is composed of
organized lymphoid tissues termed Peyer’s patches (PP),
the epithelium, lamina propria (LP) and the mesenteric
lymph nodes (Fig. 1).1 Peyer’s patches contain T and
B lymphocytes, macrophages and dendritic cells. The
lamina propria also contains dendritic cells and scattered
lymphocytes throughout including T cells and abundant
plasma cells. The epithelium contains epithelial cells and
T lymphocytes termed intraepithelial lymphocytes (IEL).
T cells play a central role in regulating immune
responses. We will focus on the response of T cells
to ingested antigen and the regulation of the immune
response by them.
RESPONSE IN PEYER’S PATCHES AND
LAMINA PROPRIA
T cells recognize antigenic peptide/major histocom-
patibility complex (MHC) complexes on the surface of
antigen-presenting cells (APC). Thus, the first step in
induction of the T cell response is antigen uptake and
antigen presentation. It has been shown that micro-
organisms in the intestinal lumen are taken up by M cells
which cover the PP and these are transferred to under-
lying macrophages and dendritic cells.2 Although it is not
clear whether soluble dietary proteins are taken up in a
similar manner, it has been demonstrated that PP-derived
dendritic cells can present antigens which they have
acquired in vivo to stimulate T cells in vitro.3 It has also
been demonstrated that intestinal dendritic cells acquire
orally administered antigen, the origin of which may be
either the PP or LP.4
Although T cell responses induced by oral administra-
tion of antigen in the PP or LP have been examined in
many studies, most have focused on the response
induced by oral administration of an antigen together
with an adjuvant such as cholera toxin. In general, domi-
nant T-helper (Th) 2 responses (secretion of interleukin
(IL)-4, IL-5 and IL-6) have been observed.5–7 Neverthe-
less, the secretion of Th1 cytokines such as IL-2 and
interferon (IFN)-g was observed in some cases.6,7 In
the case of administration without an adjuvant, Weiner
and his colleagues have consistently shown that TGF-
b -secreting cells are induced in the PP and in other sites
in the GALT.1,8,9 However, another study has shown that
cells secreting IFN-g were induced by oral administration
of antigen.10 In our own studies, we have examined T cell
responses induced by oral administration of antigen
using ovalbumin (OVA)-specific T cell receptor transgenic
(TCR-Tg) mice.11 Most T cells in these mice recognize
OVA, enabling us to amplify and detect the T cell
response to orally administered antigen. We found that
cells which are capable of secreting high levels of IL-5
are induced in the PP of the OVA-fed TCR-Tg mice
(S Kaminogawa et al., unpubl. data, 1998).
Although slightly different results have been obtained in
different systems with regard to the responses in the
PP or LP, it is likely that distinct antigen presentation or a
distinct population of T cells is responsible for the distinct
responses in these organs. With respect to this, Everson
et al. have shown that dendritic cells in the PP preferentially
induce Th2-type responses.12 In contrast, we have found
that APC populations from the PP preferentially induce a
T cell population that secretes IL-2, and IFN-g but not IL-4
or IL-10 (S Kaminogawa et al., unpubl. data, 1998). There
are also reports which suggest that GALT-derived T cells
have a distinct ability to produce cytokines. Saparov et al.
have shown that LP T cells express IFN-g or IL-10 in
response to antigenic stimulation, while spleen and PP cells
express predominantly IL-2 as determined by the in situ
hybridization technique.13 We have found that PP T cells
from unsensitized TCR-Tg mice secrete higher levels of IL-5
compared to splenic T cells in response to identical anti-
genic stimulation (S Kaminogawa et al., unpubl. data,
1998). However, the molecular bases of the induction of
the distinct responses in PP or LP remain unclear.
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Fig. 1 A schematic illustration of the gut-associated lym-
phoid tissue.
RESPONSE OF INTRAEPITHELIAL LYMPHOCYTES
Intraepithelial lymphocytes are a large population of
T lymphocytes present in the epithelial layer of villi in the
intestinal lumen. Intraepithelial lymphocytes have various
unique characteristics in that firstly, many cells express the
gd -T cell receptor and secondly, many cells express the
CD8aa homodimer.14 These cells are also distinct in
that they are of extrathymic origin. It has been unclear
whether these cells recognize antigens present in the gut
lumen. As for ab -IEL, this population has been implicated
in recognition of antigens present in intestinal micro-
organisms (or their products). This is based on previous
reports which have shown that the number of ab -IEL in
germ-free mice is fewer than that in mice housed under
conventional conditions.15 However, it is likely that the
expansion of ab -IEL in response to the intestinal flora
results from a mechanism of stimulation not involving
MHC/peptide/TCR complexes, such as superantigenic
stimulation targeted to the TCR or cytokines secreted
from epithelial cells. Although the response of IEL to
orally administered antigen has been demonstrated in
only a few studies, there is evidence that this population
does actually recognize luminal antigen. A relationship
between the number of IEL and the oral administration of
antigen has been shown for celiac disease16 and for a
food-sensitive enteropathy model established by cyclo-
phosphamide treatment.17 CD4+ IEL in orally immunized
animals have been shown to prevent parasitic infection.18
CD4+ IEL in mice orally primed with sheep red blood
cells (SRBC), secreting Th2 cytokines, were found to be
capable of providing a helper function for antigen-
specific B cell responses.19 We have found that feeding
OVA to the above mentioned TCR-Tg mice resulted in
an increased frequency and an increased proliferative
capacity of CD4+ ab -IEL (M Goto et al., unpubl. data,
1998). These IEL secreted primary IFN-g in response
to antigenic stimulation. Intestinal epithelial cells (IEC)
express class II molecules, and can present antigens to
T cells in vitro.20 Thus, orally administered antigen may be
presented by IEC in our system.
REGULATION OF LOCAL RESPONSES IN THE
GUT-ASSOCIATED LYMPHOID TISSUE
The above mentioned GALT-derived T cells regulate
immune responses to ingested antigen. The most impor-
tant of these is the induction of a secretory IgA response.
IgA not only prevents the invasion of pathogens but also
may prevent uptake of allergens.21 IgA production is
enhanced by cytokines such as TGF-b , IL-5 and IL-6.22 As
discussed, these cytokines have been shown to be
secreted by GALT-derived T cells. Much less is known
about the regulation of other reactions by T cells in
response to ingested antigen. IL-5 is known to activate
eosinophils,23 and IFN-g may mediate inflammatory
responses or act on IEC to upregulate their class II mole-
cules24 or open tight junctions.25 Such reactions may
possibly be involved in food allergy.
ORAL TOLERANCE
In addition to inducing immune responses in the gut, the
oral administration of antigen may affect systemic immune
responses. It has long been recognized in experimental
animals that oral administration of antigen induces hypo-
responsiveness of systemic immunity.1,26 Recently, this has
also been described in human studies.27
We, as well as others, have clearly demonstrated that
the state of oral tolerance is maintained principally by
CD4+ T cells.28,29 In some systems it has been reported
that the CD8+ T cell population also contributes to oral
tolerance.30 In such cases, CD8+ T cells which recognize
exogenous antigen31 are involved.
Three basic mechanisms are involved in oral tolerance:
clonal anergy, active suppression, and clonal deletion
(Fig. 2). Anergy is defined as a state of T lymphocyte
unresponsiveness characterized by the absence of prolife-
ration or IL-2 production.32 Recently, it has been shown
that the induction of anergy is mediated by signals through
CTLA-4.33 Active suppression is defined as a state of inhi-
bition of immune responses by regulatory T cells secreting
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Fig. 2 The mechanisms of oral tolerance.
inhibitory factors such as TGF-b , following antigen speci-
fic triggering.1,9 Clonal deletion is a process in which cells
are selectively destroyed via apoptosis.34 These forms of
oral tolerance are not mutually exclusive and may occur
simultaneously. All three mechanisms have been demon-
strated clearly using TCR-transgenic mice.34–36 However,
much remains to be elucidated concerning the cellular
and molecular processes involved in these phenomena.
One important issue is the site of induction of oral toler-
ance. The regulatory T cells mediating active suppression
have been shown to be induced in the GALT8,9 and dele-
tion of antigen-reactive T cells after oral administration of
antigen has been demonstrated in the PP.34 However, these
observations do not exclude the possibility that these
events may occur in other sites. It is known that orally
administered antigen enters the circulation and a recent
study has clearly demonstrated systemic presentation of
orally administered antigen,37 suggesting a role for organs
other than the GALT in the induction of oral tolerance.
There are several other important features of oral toler-
ance to note. First, the dose of antigen seems to be an
important factor in determining which form of tolerance is
induced. Low doses of antigen favor the generation of
active suppression, whereas high doses of antigen favor
anergy or deletion.38 Second, it has been demonstrated
that Th1 responses are more susceptible to tolerance induc-
tion than Th2 responses.39,40 Nevertheless, Th2 responses,
including IgE antibody responses are inhibited upon induc-
tion of oral tolerance under appropriate conditions.40–42
IGE RESPONSE INDUCED BY ORAL
ADMINISTRATION OF ANTIGEN
Oral administration of antigen induces oral tolerance in
systemic immunity and thus, administration by the oral
route is usually inefficient in inducing a systemic immune
response. However, it has been demonstrated that, in
some cases, a systemic antibody response is elicited
in response to ingested antigen. Administration of anti-
gen with adjuvant, or administration of components of
micro-organisms, efficiently induces such a response. In
addition, feeding a protein antigen without any adjuvant
may also induce a systemic response, albeit a weak
response. For example, feeding a large amount of antigen
as a constituent of the diet constantly for long periods
induces a systemic IgG response43,44 and in some cases
even an IgE response.45 Many patients allergic to food
display circulating IgE antibodies. Thus, clarifying the
mechanism underlying the induction of IgE antibodies to
ingested antigen is important in order to understand the
etiology of food allergy. However, at present this process is
poorly understood. This has mostly been due to a lack of
experimental models in which IgE antibodies are elicited
by ingested antigen. Recently, Ito et al. have shown that
oral administration of milk casein as a constituent of the
diet to DBA/2 mice elicited a serum IgE response with a
slightly enhanced Th2 response in the liver, mesenteric
lymph nodes, and spleen.45 We found that feeding OVA
as a constituent of the diet to OVA-specific TCR-Tg mice
elicited a strong serum IgE response. OVA-specific IgE
antibodies were detected 2 weeks after feeding, and the
IgE titer became elevated to levels comparable to those
induced by immunization with OVA + alum after 4 weeks
of feeding (S Kaminogawa et al., unpubl. data, 1998).
It has been hypothesized that oral tolerance is a mecha-
nism preventing food allergy in healthy individuals.46
Thus, induction of a systemic antibody response by inges-
ted antigen may be considered to be due to a breakdown
of tolerance or insufficient induction of tolerance. How-
ever, the relationship between induction of oral tolerance
and the development of an antibody response to orally
administered antigen remains unclear. In our system using
Tg mice, splenic T cells from ovalbumin (OVA)-fed mice
with a high IgE titer showed a diminished cytokine res-
ponse to antigenic stimulation, which is indicative of T cell
tolerance. However, we found that 1 week after the start of
feeding, T cells capable of secreting large amounts of IL-4
were induced in the spleen (S Kaminogawa et al., unpubl.
data, 1998). The results suggested that an aberrant
response in the induction phase of T cell tolerance resul-
ted in the development of an antibody response. Further
studies are required to clarify whether the IgE response to
an ingested allergen and food allergy are related to a
breakdown of oral tolerance.
THE T- AND B-CELL EPITOPES RECOGNIZED ON
FOOD ALLERGENS
The review will now deal with the structure of T- and B-cell
epitopes on food allergens. Such information will contri-
bute to the understanding of the fates of food allergens
after being recognized by the GALT. It is useful to know
whether the GALT has a characteristic antigen recog-
nition system.
The primary structures of several allergenic proteins
have been determined and these allergens are named
according to the recommendations of the International
Union of Immunological Societies (Table 1). It is generally
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considered that there are common structural characteris-
tics among the allergenic proteins in food (i.e. firstly,
the molecular mass is between 10 and 100 kDa and
secondly, these proteins show high stability to heat or
enzyme treatment). The structural features of OVA and
a S1-casein have been fully clarified;47–50 there have been
several reports on the determinant regions within their
amino-acid sequences recognized by T cells or B cells
(IgE or IgG) and a few reports on the functions of specific
T cells isolated.51–60 With regard to the peanut allergenic
protein Ara h2, the allergenic structure recognized by
specific IgE has been investigated61 and T cell clones
specific for crude peanut extract have been established.62
As for almost all of the other allergenic proteins, only the
binding abilities of specific-IgE to the proteins have been
analyzed. In addition, there have been several reports
of analysis performed demonstrating the cross-reactivity
between allergenic proteins in various foods, and between
food allergens and allergens in items other than food.63–65
However, there have been only a few reports on the amino
acid sequences functioning as binding regions recognized
by specific-IgE and on the isolation and characterization of
specific-T cell lines.66 Thus, although many food aller-
gens have been identified to date, the intention of this
review is mainly to introduce findings concerning OVA and
a S1-casein and the determinants on these two proteins
recognized by IgE and T cells in detail.
Ovalbumin is the major component (54%) of egg
white protein and is considered to be one of the most
important allergens in egg white. This protein is a water-
soluble glycoprotein composed of 386 amino acid
residues with a molecular mass of 45 kDa.48,49 The
molecular structure of OVA has been defined by X-ray
crystallography.50 Based on this structural information,
it has been determined that amino acid residues 1–11
of OVA (OVA1–11),52 OVA323–339,53 OVA34–46,
OVA47–55,54 and OVA41–172, OVA301–38555 are the
regions recognized by OVA-specific IgE from allergic
patients. Moreover, Honma et al. demonstrated that
OVA peptides have the ability to induce histamine
release from basophils in patients with egg allergy.56
There have been a few reports concerning the establish-
ment of OVA-specific T cell lines from such patients.57,58
Katsuki et al. studied the determinants in detail using a
panel of 187 overlapping 13 mer peptides and deter-
mined their dominant restriction elements.58 These T cell
lines were all Th2 type cells and such cells may play a
crucial role in the process of allergic inflammation
including IgE production.58
a S1-Casein is known to be one of the most significant
allergens in cow’s milk. It consists of 199 amino acid
residues and it has a flexible and linear conformation
rather than a rigid and compact one.47 These character-
istic structural features of a S1-casein are advantageous
for epitope analysis using overlapping peptides. We have
analyzed the determinants recognized by IgE, IgG4 and
T cell lines specific for a S1-casein, using synthetic over-
lapping peptides and natural fragments of this protein.60
In these analyses, a commonality of epitopes in the
C-terminal region of a S1-casein recognized by the IgE
from each of 9 patients with cow’s milk allergy was
found. The determinants recognized by IgE were included
among those recognized by IgG4, widely distributed on
a S1-casein. In addition, amino acid sequences common
to the determinants on a S1-casein recognized by Th2 type
T cell lines from each of 3 patients were found. Spuergin
et al. detected three IgE and IgG binding regions within
the amino acid sequence of a S1-casein.59
From these results of determinant analysis and studies
concerning cross-reactivity among food allergens, it
seems possible that IgE which interacts with only a
limited region on allergen proteins may be synthesized in
cases of food allergy and that this region may contain
common epitopes for IgE from various individual food
allergic patients. If so, studies clarifying the structure of
allergens may allow us to understand the etiology of
allergen-specific manifestations of food allergies. Con-
cerning this, it is necessary to analyze whether the unique
T and B cell epitope patterns in the food allergic patients
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Table 1. Major allergens in foods
Food allergen Allergen name* Mass (kDa)**
Chicken egg Gal d1 (ovalbumin) 45
Gal d2 (ovomucoid) 28
Cow’s milk a S1-casein 23
b -lactoglobulin 18.4
Soybean Gly m1A, Gly m1B 8
Gly mBd (7S globulin) 30
Peanut Ara h1 63.5
Ara h2 17.5
Brazil nut Ber e1 (2S albumin) 16–16.4
Yellow mustard Sin a1 (2S albumin) 15
Oriental mustard Bra j1 (2S albumin) 16
Codfish Gad c1 13
Shrimp Pen a1 (tropomyosin) 36
Met e1 (tropomyosin) 34
Par f1 39
Apple Mal d1 17.7
*According to the recommendations of the IUIS Subcommittee for
Allergen Nomenclature. **Molecular mass of the allergen.
already described are influenced by the digestion in
the gut.
MODULATION OF ALLERGIC REACTIONS BY
AMINO ACID-SUBSTITUTED ANALOGS OF
FOOD ALLERGEN-DERIVED PEPTIDES
Recent studies have revealed that T cells show altered
responses to amino acid-substituted analogs of a specific
peptide antigen.67,68 Some analog peptides called partial
agonists induce partial activation of T cells: for example,
cytokine production without proliferation,69 alteration
of the cytokine production pattern,70,71 and induction
of anergy,72,73 due to partial signaling. Another group of
analog peptides can inhibit T cell responses to the parent
peptide in an antigen-specific manner and these are
designated TCR antagonists.74 These analog peptides
capable of altering T cell responses are collectively called
altered peptide ligands. These are expected to be effec-
tive tools for achieving antigen-specific modulation of
immune responses in treatment of allergies, including
food allergy, and autoimmune diseases.26,75,76
In allergic patients, Th2-type responses which pro-
mote production of IgE and activation of eosinophils
seem to be dominant. This is because most of the T cell
clones specific for an allergen established from several
allergic patients show high levels of IL-4 and IL-5
production.77–80 Therefore, administration of analog
peptides preferentially inducing production of IFN-g ,81
which is a potent inhibitor of Th2-type responses, would
be effective for inhibiting the onset of allergy or remit-
ting the symptoms. We have identified an analog of a
peptide derived from a S1-casein, which significantly
enhances IFN- g production from specific CD8+ T cells in
vivo in a mouse model.82 From patients allergic to
a S1-casein, CD8+ T cell lines specific for a S1-casein have
been established in high frequency.83 Given that these
CD8+ T cells play a key role in suppressing the allergic
reactions, an analog peptide with enhanced ability to
induce IFN- g production from CD8+ T cells may be
useful for the treatment of allergic patients.
Several reports have shown inhibitory effects of TCR
antagonist peptides in vivo on the onset of T cell-mediated
experimental autoimmune diseases, such as experimental
allergic encephalomyelitis84–87 and experimental allergic
uveitis.88 In antibody-mediated immune diseases, such as
type I allergy, inhibition of pathogenic antibody produc-
tion as well as inhibition of T cell responses is crucial to
ameliorate the disease. We have examined the effect of a
TCR antagonist peptide on specific-antibody production
in vivo in a mouse model. A TCR antagonist peptide, an
analog of a peptide derived from b -lactoglobulin, which
is a major cow’s milk allergen, efficiently inhibited the
production of antibodies, including IgE, specific for the
b -lactoglobulin-peptide, when the TCR antagonist was
co-administered with the parent peptide at the time of the
first immunization (S Kaminogawa, unpubl. data, 1998).
Our results suggest that TCR antagonists may be highly
effective as preventive inhibitors of pathogenic-antibody
production in food allergic patients.
CONCLUSION
It was our purpose to describe how ingested food aller-
gens up-regulate IgA and IgE production and down-
regulate peripheral immune responses (oral tolerance)
through the mucosal immune system. How food allergens
are bound by IgE and T cell receptors and the site of IgE
production are other important issues which have yet to
be clearly described. Thus, we believe that the elucidation
of these aspects will lead to a fuller understanding of the
mechanism of generation of food allergy and other
immunologically mediated diseases such as Crohn’s
disease. However, there are many important problems
not mentioned in this review. For example, how immuno-
logic interactions between the GALT and intestinal
bacteria affect the mucosal and systemic peripheral
immune responses. We hope to have the opportunity to
understand and describe these issues in the future.
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